You are here

Halving the TKI dose safe, cost effective in CML patients with stable remissions. Destiny.

Categories:

Sorry if this has been posted before.

 

Here are some uplifting information from the Destiny trial.

 

http://www.mdedge.com/hematologynews/article/119417/cml/halving-tki-dose...

http://www.mdedge.com/hematologynews/article/119426/cml/video-half-dose-...

 

Thanks for the links Teddyb, we have posted an abstract from ASH on this but this is a more detailed report and will be helpful to more people. I hope you are doing well.

Sandy 

Thanks Sandy, i will read up on those.

Exiting times, i too am hoping of reducing the dosage at some point.

Bloodwork is good, pcr is low and stable, so i guess i am doing pretty well except for some side effects.

Hope all is well with you as well :)